Search Results

Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study).

• Authors : Chiricozzi A; U.O.C. di Dermatologia, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.

Subjects: Quality of Life* ; Psoriasis*/Psoriasis*/Psoriasis*/drug therapy; Humans

• Source: The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2246606.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print Cited Medium: Internet ISSN: 1471-1753

Record details

Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy.

• Authors : Dastoli S; Department of Health Sciences, Magna Graecia University, Catanzaro, Italy.; Passante M

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/adverse effects ; Psoriasis*/Psoriasis*/Psoriasis*/drug therapy ; Psoriasis*/Psoriasis*/Psoriasis*/chemically induced

• Source: The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2200868.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print Cited Medium: Internet ISSN: 1471-1753

Record details

Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis).

• Authors : Gargiulo L; Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

Subjects: Psoriasis*/Psoriasis*/Psoriasis*/drug therapy ; Psoriasis*/Psoriasis*/Psoriasis*/pathology ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage

• Source: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2350760. Date of Electronic Publication: 2024 May 07.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study.

• Authors : Ricceri F; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.; Bardazzi F

Subjects: Lymphopenia* ; Psoriasis*/Psoriasis*/Psoriasis*/drug therapy; Aged

• Source: The Journal of dermatological treatment [J Dermatolog Treat] 2022 Jun; Vol. 33 (4), pp. 2000-2003. Date of Electronic Publication: 2021 Aug 11.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

2-Year Experience with Risankizumab in the Treatment of Plaque Psoriasis in Lazio Region, Italy.

• Authors : Caldarola, Giacomo^1,2 (AUTHOR); De Luca, Eleonora^1,2 (AUTHOR); Bavetta, Mauro³ (AUTHOR)

• Source: Dermatologic Therapy. 9/19/2023, p1-6. 6p.

Record details

Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis.

• Authors : Membrive-Jiménez, Cristina¹ (AUTHOR) ; Pérez-Ramírez, Cristina² (AUTHOR) ; Arias-Santiago, Salvador³ (AUTHOR)

Subjects: *BIOTHERAPY; *TUMOR necrosis factors; *PSORIASISITALY; SPAIN

• Source: International Journal of Molecular Sciences. May2023, Vol. 24 Issue 10, p8703. 18p.

Record details

Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement.

• Authors : Fargnoli, Maria Concetta^1,2 (AUTHOR) ; Bardazzi, Federico³ (AUTHOR) ; Bianchi, Luca^4,5 (AUTHOR)

• Source: Journal of Clinical Medicine. May2023, Vol. 12 Issue 10, p3545. 15p.

Record details

Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.

• Authors : Talamonti M; Malara G ...

Subjects: Depression*/Depression*/Depression*/diagnosis ; Depression*/Depression*/Depression*/drug therapy ; Psoriasis*/Psoriasis*/Psoriasis*/diagnosis

• Source: Acta dermato-venereologica [Acta Derm Venereol] 2021 Mar 31; Vol. 101 (3), pp. adv00422. Date of Electronic Publication: 2021 Mar 31.Publisher: Society for the Publication of Acta Dermato-Venereologica Country of Publication: Sweden NLM ID: 0370310 Publication Model: Electronic Cited

Record details

A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study.

• Authors : Zagni E; Novartis Farma S.p.A, Largo Umberto Boccioni, 1, 21040, Origgio, Varese, Italy. .; Bianchi L

Subjects: Psoriasis*/Psoriasis*/Psoriasis*/drug therapy ; Quality of Life*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/therapeutic use

• Source: BMC health services research [BMC Health Serv Res] 2021 Sep 06; Vol. 21 (1), pp. 924. Date of Electronic Publication: 2021 Sep 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963

Record details

Psoriatic patients undergoing long-term therapy with biologics: Impact of residual localization of psoriasis on quality of life in an Italian clinical setting.

• Authors : Muslimani MA; Institute of Dermatology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.; Bolcato V

Subjects: Biological Products*/Biological Products*/Biological Products*/adverse effects ; Psoriasis*/Psoriasis*/Psoriasis*/diagnosis ; Psoriasis*/Psoriasis*/Psoriasis*/drug therapy

• Source: Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14337. Date of Electronic Publication: 2020 Oct 03.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details